China Medical University Hospital and Shine-On Biomedical Advance Targeted Exosome Therapy into U.S. Clinical Trials

On June 2, China Medical University Hospital (CMUH) announced that a research team led by Superintendent Der-Yang Cho, in collaboration with Shine-On Biomedical, has successfully developed the world’s first targeted exosome drug delivery platform for HLA-G—SOB100. This breakthrough was published in the prestigious international journal Nature Communications and received approval from the U.S. FDA on March 8 to enter Phase I human clinical trials.